Allarity Therapeutics, Inc. Income Taxes Paid
Allarity Therapeutics, Inc. (ALLR) reported Income Taxes Paid of $6.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2024-08-05
- Allarity Therapeutics, Inc. income taxes paid for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. income taxes paid for the quarter ending 2023-09-30 was $0.00.
- Allarity Therapeutics, Inc. income taxes paid for the quarter ending 2023-06-30 was $0.00.
- Allarity Therapeutics, Inc. income taxes paid for the quarter ending 2023-03-31 was $6.00K, a 500.00% increase year-over-year.
- Allarity Therapeutics, Inc. income taxes paid for fiscal 2023 was $6.00K, a 50.00% decline from fiscal 2022.
- Allarity Therapeutics, Inc. income taxes paid for fiscal 2022 was $12.00K, a 89.83% decline from fiscal 2021.
- Allarity Therapeutics, Inc. income taxes paid for fiscal 2021 was $118.00K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-05 | $6.00K 10-K · filed 2024-03-08 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-08-05 | $6.00K 10-Q · filed 2023-11-14 | $17.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $6.00K 10-Q · filed 2024-08-05 | $17.00K derived: sum of 3 quarters · filed 2024-08-05 | $17.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-14 | $17.00K derived: sum of 2 quarters · filed 2024-05-14 | $17.00K derived: sum of 3 quarters · filed 2024-05-14 | $17.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $11.00K derived: sum of 2 quarters · filed 2024-03-08 | $11.00K derived: sum of 3 quarters · filed 2024-03-08 | $12.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $1.00K 10-Q · filed 2023-11-14 | $70.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.00K 10-Q · filed 2023-08-14 | $70.00K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-11 | $70.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $118.00K 10-K · filed 2023-03-13 | ||
| 2021-09-30 | $49.00K 10-Q · filed 2022-11-14 | |||
| 2020-09-30 | $20.00K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |